Literature DB >> 11079041

The pathogenesis of Barrett's esophagus: a process in continuum or discontinuum.

R C Fitzgerald1, M J Farthing.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 11079041     DOI: 10.1007/s11894-000-0001-4

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


× No keyword cloud information.
  51 in total

1.  Cyclooxygenase-2 in Barrett's esophagus, Barrett's adenocarcinomas, and esophageal SCC: ready for clinical trials.

Authors:  R V Lord; K D Danenberg; P V Danenberg
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

2.  The normal human esophageal mucosa: a histological reappraisal.

Authors:  W M Weinstein; E R Bogoch; K L Bowes
Journal:  Gastroenterology       Date:  1975-01       Impact factor: 22.682

3.  Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure.

Authors:  V N Shirvani; R Ouatu-Lascar; B S Kaur; M B Omary; G Triadafilopoulos
Journal:  Gastroenterology       Date:  2000-03       Impact factor: 22.682

4.  Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model.

Authors:  R C Fitzgerald; M B Omary; G Triadafilopoulos
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: correlation with disease activity.

Authors:  S Inoue; T Matsumoto; M Iida; M Mizuno; F Kuroki; K Hoshika; M Shimizu
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

6.  Oesophageal histology in reflux oesophagitis.

Authors:  B J Collins; H Elliott; J M Sloan; R J McFarland; A H Love
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

7.  The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-alpha and interleukin-4 predicts improved survival.

Authors:  R J Barth; B J Camp; T A Martuscello; B J Dain; V A Memoli
Journal:  Cancer       Date:  1996-09-15       Impact factor: 6.860

8.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

9.  [Biopsy and endoscopic prospective study of the prevalence of intestinal metaplasia in the gastroesophageal junction in controls and in patients with gastroesophageal reflux].

Authors:  A Csendes; G Smok; H Sagastume; J Rojas
Journal:  Rev Med Chil       Date:  1998-02       Impact factor: 0.553

10.  Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.

Authors:  D A Katzka; D O Castell
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.